Studies on Drug-induced Lipidosis:VI. Identification and Determination of the Drug and Its Metabolite in Lipidosis Induced by 4, 4'-Diethylaminoethoxyhexestrol

J-STAGE
  • MATSUZAWA Yuji
    The Second Department of Internal Medicine, Osaka University Medical School
  • YOKOMURA Tohru
    The Second Department of Internal Medicine, Osaka University Medical School
  • ISHIKAWA Katsunori
    The Second Department of Internal Medicine, Osaka University Medical School
  • ADACHI Susumu
    The Second Department of Internal Medicine, Osaka University Medical School
  • YAMAMOTO Akira
    The Second Department of Internal Medicine, Osaka University Medical School

この論文をさがす

説明

In clinical cases of lipidosis or foam cell syndrome caused by an administration of 4, 4'-diethylaminoethoxyhexestrol, the drug was found to accumulate in liver and some other tissues. In liver specimens obtained from patients who had been administered this drug at a level of 75-150 mg per day for more than 6 months, the concentration of the drug remaining in the liver was 0.21-0.74 percent of the wet weight of the tissue. Molar ratio of the sum of the drug and free cholesterol to the sum of the acidic phospholipids was 2.11±0.83. The results suggested that the drug was participating in the formation of myeline-like structure together with acidic phospholipids and free cholesterol.<br> The drug metabolite in rat liver was extracted and purified by phase partitioning and preparative TLC. Instrumental analysis by infra-red spectroscopy, nuclear magnetic resonance and mass spectroscopy showed that the major metabolite in rat liver was a derivative of 4, 4'-diethylaminoethoxyhexestrol which had one hydroxyl group in the benzene ring. It was concluded that rat liver has an ability to oxidize the drug, while human livers lack in this ability.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ